Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 21;7(12):ofz367. doi: 10.1093/ofid/ofz367

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2019.

This work is written by (a) US Government employee(s) and is in the public domain in the US. This Open Access article contains public sector information licensed under the Open Government Licence v2.0 (http://www.nationalarchives.gov.uk/doc/open-government-licence/version/2/).

PMC Copyright notice

Figure 2. — Gut bacterial changes in HIV+ pre–antiretroviral therapy (ART) and HIV+ post-ART. A, Cladogram of linear discriminant analysis (LDA) effect size highlights discriminatory taxa, with an LDA score >2, between HIV+ pre-ART and HIV+ post-ART. B, Percentage of the top 20 most abundant families in HIV-, HIV+ pre-ART, and HIV+ post-ART (permutation test: HIV- vs HIV+ pre-ART, P = .6; HIV- vs HIV+ post-ART, P = .4; HIV+ pre-ART vs HIV+ post-ART, P = .3). C, LDA scores of differentially abundant taxa among HIV+ pre-ART at F1-2 and HIV+ pre-ART at F3. D, LDA scores of differentially abundant taxa among HIV+ pre-ART at F1-2 and HIV+ post-ART at F1-2. E, LDA scores of differentially abundant taxa among HIV+ pre-ART at F3 and HIV+ post-ART at F3.

Figure 2. — Gut bacterial changes in HIV+ pre–antiretroviral therapy (ART) and HIV+ post-ART. A, Cladogram of linear discriminant analysis (LDA) effect size highlights discriminatory taxa, with an LDA score >2, between HIV+ pre-ART and HIV+ post-ART. B, Percentage of the top 20 most abundant families in HIV-, HIV+ pre-ART, and HIV+ post-ART (permutation test: HIV- vs HIV+ pre-ART, P = .6; HIV- vs HIV+ post-ART, P = .4; HIV+ pre-ART vs HIV+ post-ART, P = .3). C, LDA scores of differentially abundant taxa among HIV+ pre-ART at F1-2 and HIV+ pre-ART at F3. D, LDA scores of differentially abundant taxa among HIV+ pre-ART at F1-2 and HIV+ post-ART at F1-2. E, LDA scores of differentially abundant taxa among HIV+ pre-ART at F3 and HIV+ post-ART at F3.